57.20
+0.07
+(0.12%)
At close: March 24 at 1:47:47 PM CST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARBIER REMI Chief Executive Officer | Conversion of Exercise of derivative security | May 24, 2023 | -- |
| BARRY RICHARD J Director | Conversion of Exercise of derivative security | Apr 23, 2024 | -- |
| GUSSIN ROBERT Z Director | Conversion of Exercise of derivative security | May 1, 2023 | 10,617 |
| KUPIEC JAMES WILLIAM Officer | Sale | Nov 29, 2024 | 0 |
| ROBERTSON SANFORD R Director | Stock Gift | May 16, 2024 | 1,135,850 |
| SCANNON PATRICK J M.D., PH.D. Director | Conversion of Exercise of derivative security | Jun 12, 2023 | 1,000 |
| SCHOEN ERIC J. Chief Financial Officer | Sale | Nov 29, 2024 | -- |
Related Tickers
12X1.F Anavex Life Sciences Corp.
7.85
-0.83%
HOTH Hoth Therapeutics, Inc.
0.8064
-2.27%
IVVD Invivyd, Inc.
0.5140
-2.11%
SANA Sana Biotechnology, Inc.
1.7000
-6.08%
AVXL Anavex Life Sciences Corp.
9.12
+3.40%
SRPT Sarepta Therapeutics, Inc.
54.42
-0.38%
MURA Mural Oncology plc
2.4100
+133.98%
MRNA Moderna, Inc.
26.24
-2.09%
NVAX Novavax, Inc.
6.39
-0.31%